The effect of continuous subcutaneous recombinant PTH (1-34) infusion during pregnancy on calcium homeostasis-a case report

Jacob Ilany, Iris Vered, Ohad Cohen*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Objective: We describe calcium homeostasis during pregestation and gestation in a woman with iatrogenic hypoparathyroidism, treated with continuous subcutaneous recombinant parathyroid hormone (PTH) (1-34) infusion. Results: The requirement for PTH did not fluctuate much during pregnancy and was essential for maintaining normal calcium and phosphorus serum levels. Conclusions: This study documents the insufficiency of PTH-related protein (PTHrP) or other gestation-related hormones to compensate for PTH deficiency in hypoparathyroid women, and the successful utilization of continuous subcutaneous recombinant PTH (1-34) infusion to achieve normal calcium homeostasis during gestation. Clinical trials with PTH replacement in such circumstances are warranted.

Original languageEnglish
Pages (from-to)807-810
Number of pages4
JournalGynecological Endocrinology
Volume29
Issue number9
DOIs
StatePublished - Sep 2013
Externally publishedYes

Keywords

  • Calcium
  • PTH
  • Pregnancy

Fingerprint

Dive into the research topics of 'The effect of continuous subcutaneous recombinant PTH (1-34) infusion during pregnancy on calcium homeostasis-a case report'. Together they form a unique fingerprint.

Cite this